Nitroxides as Protectors Against Oxidative Stress
氮氧化物作为氧化应激的保护剂
基本信息
- 批准号:7066867
- 负责人:
- 金额:--
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:antioxidantscadherinscytoprotectioncytotoxicitydrug screening /evaluationelectron spin resonance spectroscopyfree radical scavengersgene expression profilingglutathioneheat shock proteinsionizing radiationlaboratory mouseneoplastic cellnitrogen oxidesoxidation reduction reactionoxidative stressoxidizing agentspiperidineradiation protectionradioprotective agentssuperoxide dismutasetissue /cell culture
项目摘要
Nitroxides as Protectors against Oxidative StressExtensive studies in our laboratory have demonstrated that nitroxides (such as Tempol) are effective antioxidants and protectors against ionizing radiation damage. We have previously demonstrated that the potential mechanism(s) for nitroxide-mediated protection against oxidative stress include superoxide dismutase- and catalase-like activity and radical-radical reactions. However, more recent studies have focused on whether nitroxide treatment impacts gene expression. Cells treated with non-toxic concentrations of several different nitroxide analogues; including a nitroxide incapable of cellular entry (and protection) all exhibit similar patterns of gene expression. Prominent genes up-regulated by nitroxide treatment include the heat shock protein (HSP) family, reductive enzyme genes, and genes associated with the Wnt/beta-catenin pathway. We are currently comparing nitroxide-mediated gene expression profiles with other forms of oxidative stress including hydrogen peroxide, superoxide, and ionizing radiation. Additionally we are conducting gene expression studies of selected tissues taken from animals maintained on Tempol in the food. We have shown that long-term administration of Tempol (in the food or drinking water) results in dramatic weight reduction and a decrease in spontaneous tumor incidence in mice. Recently we have shown that Tempol administration delays the onset of tumors in Atm deficient mice. These studies will hopefully enable us to better understand the complex cellular/molecular mechanisms of nitroxides that trigger responses important in the antioxidant properties of nitroxides as well as those related to weight and the chemopreventive findings. Lastly, we are continuing our studies on the differential radioprotection of Tempol toward normal tissues as opposed to tumor. Recent studies indicate that Tempol administered 10 min prior to fractionated radiation treatment does not protect SCC and HT-29 tumor growth. We have recently shown that nitroxides administered prior to radiation protects against salivary gland damage and preliminary studies show protection against radiation-induced. Mucositis and damage to the rectum. A recent phase I clinical trial has shown that topically applied nitroxides protect against alopecia for patients receiving whole brain radiotherapy. Our pre-clinical studies support the concept that nitroxides such as Tempol will provide selective radioprotection of normal tissues. Since nitroxides readily penetrate cell membranes and are potent antioxidants, they may be of use in other areas of medical research such as ischemia/reperfusion injury studies, prevention of cataracts, inflammatory processes, and aging.
我们实验室的大量研究表明,氮氧化物(如Tempol)是有效的抗氧化剂和抗电离辐射损伤的保护剂。我们之前已经证明了氮氧化物介导的抗氧化应激保护的潜在机制包括超氧化物歧化酶和过氧化氢酶样活性以及自由基-自由基反应。然而,最近更多的研究集中在氮氧化物处理是否影响基因表达。用无毒浓度的几种不同的氮氧化物类似物处理细胞;包括不能进入(和保护)细胞的氮氧化物都表现出相似的基因表达模式。受氮氧化物处理上调的主要基因包括热休克蛋白(HSP)家族、还原酶基因以及与Wnt/ β -连环蛋白通路相关的基因。我们目前正在比较氮氧化物介导的基因表达谱与其他形式的氧化应激,包括过氧化氢、超氧化物和电离辐射。此外,我们正在对食物中Tempol饲养动物的特定组织进行基因表达研究。我们已经证明,长期服用Tempol(在食物或饮用水中)可以显著减轻小鼠的体重,并减少自发性肿瘤的发病率。最近我们已经表明,Tempol管理延迟肿瘤的发生在Atm缺陷小鼠。这些研究有望使我们更好地了解氮氧化物的复杂细胞/分子机制,这些机制触发了氮氧化物抗氧化性能的重要反应,以及与体重和化学预防相关的反应。最后,我们正在继续研究Tempol对正常组织和肿瘤的差异辐射防护。最近的研究表明,在分级放射治疗前10分钟给予Tempol并不能保护SCC和HT-29肿瘤的生长。我们最近表明,在辐射前施用氮氧化物可以防止唾液腺损伤,初步研究表明可以防止辐射引起的损伤。粘膜炎和直肠损伤。最近一期临床试验表明,局部应用氮氧化物对接受全脑放疗的患者预防脱发。我们的临床前研究支持氮氧化物(如Tempol)对正常组织提供选择性辐射防护的概念。由于氮氧化物很容易穿透细胞膜,是有效的抗氧化剂,它们可能用于其他医学研究领域,如缺血/再灌注损伤研究,预防白内障,炎症过程和衰老。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JAMES MITCHELL其他文献
JAMES MITCHELL的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JAMES MITCHELL', 18)}}的其他基金
A PHASE I STUDY OF 2-CHLORODEOXYADENOSINE AND RADIATION FOR THE TREATMENT OF HIGH
2-氯脱氧腺苷和放射治疗高血压的 I 期研究
- 批准号:
6290833 - 财政年份:
- 资助金额:
-- - 项目类别:
A PHASE I STUDY OF HYDROXYUREA AND PENTOXIFYLLINE FOR TREATMENT OF GLIOBLASTOMA
羟基脲和己酮可可碱治疗胶质母细胞瘤的 I 期研究
- 批准号:
6290788 - 财政年份:
- 资助金额:
-- - 项目类别:
相似国自然基金
增生性玻璃体视网膜病变早期钙黏蛋白(Cadherins)异常表达启动视网膜色素上皮细胞游离的分子机制
- 批准号:81770939
- 批准年份:2017
- 资助金额:56.0 万元
- 项目类别:面上项目
Beta-catenin/Cadherins, EphBs 在平衡颅神经嵴细胞的粘附和迁徙机制的研究
- 批准号:81400494
- 批准年份:2014
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
Cadherins与nectins在青少年期慢性社会应激损害小鼠前额叶形态可塑性与功能中的作用
- 批准号:81401129
- 批准年份:2014
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Role of Glycosylation of Dsg1 in Pemphigus acantholysis
Dsg1 糖基化在棘层松解型天疱疮中的作用
- 批准号:
6970388 - 财政年份:2005
- 资助金额:
-- - 项目类别:
Role of Glycosylation of Dsg1 in Pemphigus acantholysis
Dsg1 糖基化在棘层松解型天疱疮中的作用
- 批准号:
7124241 - 财政年份:2005
- 资助金额:
-- - 项目类别:
LUNG VASCULAR BARRIER PRESERVATION BY PLATELET PRODUCTS
通过血小板产品保护肺血管屏障
- 批准号:
6435168 - 财政年份:2001
- 资助金额:
-- - 项目类别:














{{item.name}}会员




